Abstract
Patients suffering from cancer are at risk for arrhythmias due to their disease, comorbidities, and treatments. This article reviews the various sources of arrhythmia risk in the cancer patient. Chemotherapy-associated arrhythmias are described based upon drug class. Radiation-associated arrhythmias and radiation-associated cardiac implantable electronic device malfunction are described. Finally, this article reviews QT interval monitoring and prevention and management of QT prolongation.
| Original language | English (US) |
|---|---|
| Title of host publication | Encyclopedia of Cardiovascular Research and Medicine |
| Publisher | Elsevier |
| Pages | 162-181 |
| Number of pages | 20 |
| Volume | 1-4 |
| ISBN (Electronic) | 9780128051542 |
| ISBN (Print) | 9780128096574 |
| DOIs | |
| State | Published - Jan 1 2017 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Arrhythmia
- Chemotherapy
- QT prolongation
- Radiation
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Arrhythmias in Cancer and Cancer Treatment: A Review'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS